atai Life Sciences (ATAI) Tops Q3 EPS by 45c

atai Life Sciences (NASDAQ: ATAI) reported Q3 EPS of $0.25, $0.45 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Old Dominion Freight Line (ODFL) Reiterated at Buy by Stifel Amid Seasonally Softer Q4/Q1
• Ardent Health revises 2025 non-GAAP figures after SEC staff talks